News

A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

The Washington Times By Lauran Neergaard Oct 22, 2026 · 5:23 PM 0 views 0 comments

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.

The Washington Times Original story · www.washingtontimes.com

Read the full story

How does this story make you feel?

👍 ❤️ 💡 😮 😂 😢 😠

Discussion (0)

No comments yet. Start the conversation!

Discussion (0)

More to read

First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study

Moderna Shares Plunge After Leak of Cancer Vaccine Data

A cancer vaccine is reducing the chances that melanoma patients’ tumors return